HHS Nominee Tom Price Targeted Panel That Urged Fewer Cancer Screenings

If the last few years are any guide, one group that may find itself in the crosshairs of Rep. Tom Price, President Trump’s pick to lead the Department of Health and Human Services, is an influential panel of medical experts. The U.S. Preventative Services Task Force, a group of mostly physician and academics from top universities, reviews medical practices to see whether they are supported by research and evidence.

KanCare reform measures grab the attention of House, Senate committees

House Minority Leader Jim Ward, D-Wichita, testifies as a proponent to bringing the inspector general out of the Kansas Department of Health and Environment, the agency overseeing KanCare, and into the attorney generals office during a hearing with the House Health and Human Services Committee Tuesday afternoon. State Medicaid director Mike Randol testifies during Tuesday afternoon’s House Health and Human Services Committee as they discussed bringing the inspector general out of the Kansas Department of Health and Environment, the agency overseeing KanCare, and into the attorney generals office.

Aevi Genomic Medicine Announces Enrollment of First Patient in Phase…

“We are pleased to have the first patient enrolled into this important study,” said Garry Neil, Chief Scientific Officer of Aevi Genomic Medicine. “Patients with 22q Deletion Syndrome often suffer from a range of debilitating psychiatric conditions, including anxiety disorders, ASD, and ADHD, with many patients progressing to psychosis and schizophrenia.

Dimension Announces Interim Topline Results from Ongoing Phase 1/2…

Dimension Announces Interim Topline Results from Ongoing Phase 1/2 Clinical Program for DTX101, Dimension’s Lead AAV Product Candidate in Development for Adult Patients with Moderate/Severe to Severe Hemophilia B CAMBRIDGE, Mass., Jan. 31, 2017 — Dimension Therapeutics, Inc. , a biopharmaceutical company advancing novel, adeno-associated virus gene therapies targeting the liver, a key organ for human metabolism, today announced preliminary topline safety and early efficacy results of Dimension’s multi-center phase 1/2 study of DTX101 for the treatment of adult patients with moderate/severe to severe hemophilia B. DTX101, Dimension’s lead AAV candidate, is designed to deliver stable expression of blood clotting Factor IX in patients with hemophilia B, a rare genetic bleeding disorder resulting from a deficiency in FIX.

Uncertain future for Californiaa s anti-smog efforts: Thomas Elias

Cases of chronic obstructive pulmonary disease are down about three percent over the last 40 years in California, even as state population is up by well over one-third, better than 15 million, and far more smog-belching vehicles than ever clog the roads. This is a major public health achievement, and the single biggest reason behind it is the 45-year-old federal Clean Air Act and its provisions for California waivers.

Commentary: Trump and Obama’s legacy

… to go down in history. Obamacare was passed into law to give some 20 million Americans the opportunity to purchase health Insurance through private Insurance companies subsidized by the Federal government. But from the start it wasn’t presented …

Is it still worth signing up for Obamacare?

Chief among them is that the last day to enroll for health care insurance in 2017 is Tuesday, Jan. 31. Second, despite the confusion about Obamacare’s future, people who sign up before the deadline will lock in coverage for the year, as well their tax subsidies. What happens to the law into 2018 remains unclear, however.

CytoDyn Strengthens Executive Management With Appointment of Anthony…

CytoDyn Inc. , a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus infection, announces the appointment of Anthony D. Caracciolo as Executive Chairman of CytoDyn effective immediately. In this new capacity, Mr. Caracciolo will assume an active leadership role in the Company’s strategic planning, business development and operations.

3 Biotech Stocks I’d Buy Right Now

Despite the sway of political uncertainty for the biotechnology industry at the moment, these three stocks look like great buys right now. Conflicting statements from the Trump administration have made owning biotech stocks feel like a roller-coaster ride in recent weeks, but there are a few stocks I’d happily buy and hold despite the sway of political uncertainty.

Guess Who Can’t Wait for Trumpcare?

… hasn’t been a particularly popular law since its passage in March 2010. According to the Kaiser Family Foundation Health Tracking Poll, which has been conducted on a near-monthly basis since Obamacare’s passage, just a handful of months have …

Obamacare Repeal Could Threaten Provisions That Help Older Adults

Republican lawmakers meeting in Philadelphia this week say they want their replacement of Obamacare to be done by spring. There is no consensus on a plan yet, but several Republicans in Congress have already circulated proposals that could reduce or eliminate features of the federal health law that have benefited older Americans.

NORC Poll: Broad worries about potentiala

Though “Obamacare” still divides Americans, a majority worry that many will lose coverage if the 2010 law is repealed in the nation’s long-running political standoff over health care. AP-NORC Poll: Broad worries about potential health care loss WASHINGTON – Though “Obamacare” still divides Americans, a majority worry that many will lose coverage if the 2010 law is repealed in the nation’s long-running political standoff over health care.

Covered California: Trump move to kill ACA ads fails

The Trump administration’s decision to cancel $5 million in advertising the federal government had already paid for to remind Americans of Tuesday’s 2017 open enrollment deadline for Obamacare will have little impact in the Golden State. That’s because Covered California, the state’s health insurance exchange established under the Affordable Care Act, is not federally directed or funded.

Affordable Care Act enrollment ongoing, despite Trump pulling ads

Despite the Trump administration recently pulling the plug on all advertisements and marketing for the Affordable Care Act’s current open enrollment period, anyone can still sign up for health care insurance under the law through the end of the month. Erin Knot, the Michigan director for Enroll America, doesn’t expect anyone would lose their coverage immediately if Republican lawmakers carry out their promise to repeal Obamacare this year.

Area health care leaders in the dark about industry’s future

The uncertainty of health care under a new president was among the topics discussed Thursday at the 2017 State of Healthcare Forum. JOHN GODBEY/DECATUR DAILY Area health care professionals are trying to better manage the existing health care system while guessing about future changes now that a new administration has taken office in Washington, D.C. “If we don’t figure out how to ration health care, the cost of premiums could be $3,000 a month,” said David Spillers, chief executive officer of the Huntsville Hospital Health System.

Hawaii pols propose bill that would classify homelessness as medical condition

As an emergency room doctor, Hawaii Sen. Josh Green sees homeless patients suffering from diabetes, mental health problems and an array of medical issues that are more difficult to manage when they are homeless or do not have permanent housing. “It is paradigm shift for sure, but the single best thing we can do today is to allow physicians and health care providers in general to write prescriptions for housing,” Green said.

Trump administration pulls back on HealthCare.gov ads

The Trump administration said Thursday night it is pulling back advertising to promote HealthCare.gov as open enrollment draws to a close for this year. The Health and Human Services Department said in a statement that the government has pulled back about $5 million in ads as part of an effort to cut costs.

Hawaii bill would classify homelessness as medical condition

As an emergency room doctor, Hawaii Sen. Josh Green sees homeless patients suffering from diabetes, mental health problems and an array of medical issues that are more difficult to manage when they are homeless or do not have permanent housing. “It is paradigm shift for sure, but the single best thing we can do today is to allow physicians and health care providers in general to write prescriptions for housing,” Green said.